Sleep Disorders Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a blood cancer diagnosis and whose treatment has been stable (no changes to cancer-related medications in the past two weeks), whether on a steady medication plan or under observation
- People who are not currently taking part in another clinical trial that involves a drug or treatment
- People who are not planning to receive a donor stem cell transplant within the next 20 weeks
- People who have scored above 5 on a standard sleep quality questionnaire called the Pittsburgh Sleep Quality Index, which suggests poor sleep quality
- People who own a smartphone (an iPhone running iOS 14 or newer, or an Android phone running version 6 or newer) with an active mobile data or WiFi connection
- People who are willing to download two mobile apps onto their phone
- People who are able to read and understand English
- People who are 18 years of age or older
- People who are willing to be randomly assigned to a study group
- People who are willing to travel to a nearby lab for blood draws three times over the 20-week study period
- People who use sleep medications or over-the-counter sleep aids on fewer than three nights per week, and who are either willing to keep that use exactly the same throughout the 20 weeks, or willing to stop using them if a doctor has prescribed them on an "as needed" basis
Who may not be able to join:
- People who already practise meditation, yoga, tai chi, qi gong, or similar mindful movement for 60 minutes or more per week and have been doing so for the past two months
- People who live outside of the United States of America
- People whose doctor is planning to start them on a new cancer medication during the study (dose changes to existing medications are not included in this restriction — confirm with trial site)
- People who have been diagnosed with a sleep disorder other than insomnia, such as sleep apnoea, identified through a screening questionnaire called the Berlin Questionnaire
- People who use prescribed or over-the-counter sleep aids (including products like NyQuil, Benadryl, or other antihistamine-based sleep products) on three or more nights per week
- People who have another medical or psychiatric condition that is diagnosed and not currently under control
- People who have a pacemaker
- People who work shift work schedules
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Jennifer Huberty, PhD, The University of Texas Health Science Center at San Antonio
Phone: 814-424-5601
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Sleep Disturbance (subjective); Sleep Disturbance (subjective); Sleep Disturbance (subjective); Sleep disturbance (subjective); Sleep disturbance (objective)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.